Article summary
The European Medicines Agency (EMA) has published electronic product information (ePI) for selected human medicines. In line with the EU ePI Common Standard, the ePIs aim to provide a consistent structure throughout all Member States and ensure the information works across different e-health platforms. A one-year pilot has been launched to create and test ePIs and enable the transition to the electronic system for medicines evaluated nationally and at a European level. The ePIs, containing a summary of the medicine’s characteristics, labelling and package leaflet, accompany every authorised medicine in the EU and explain how they should be used and prescribed. Future developments could include functionalities such as automatic update notifications, access to supportive videos or audio content and online adverse-reaction.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial